Launch of RLT Angels (June 2025)

EANM is proud to be a founding partner of RLT Angels – a new global non-profit initiative dedicated to maximising patient access to Radioligand Therapy (RLT).

The main objectives are closely aligned with the interests of our community, aiming to create open-source best practice resources such as global blueprints and tools for process optimisation. These resources will help centres expand their expertise and capacity while improving the patient experience. In addition, RLT Angels will offer virtual support and host online expert forums to help centres make the most of these resources.

Powered by world-class scientific expertise, RLT Angels Association brings together key stakeholders, including EANM, GE HealthCare, ICPO Foundation-International Centers for Precision Oncology, Novartis, and RayzeBio (a Bristol Myers Squibb company). EANM President Paola Anna Erba has been appointed Vice-President of the RLT Angels Board.

If you are interested in contributing your expertise to the RLT Angels Scientific Advisory Board, please contact the EANM Executive Office via Silvia Marchetti at s.marchetti@eanm.org.

To learn more, make sure to check out the RLT Angels website (and its very first press release), and follow their LinkedIn page to stay up to date.

Find out more

Published online: June 23, 2025.